{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T08:47:49Z","timestamp":1781081269403,"version":"3.54.1"},"reference-count":99,"publisher":"Wiley","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd000207","type":"journal-article","created":{"date-parts":[[2003,11,21]],"date-time":"2003-11-21T03:14:00Z","timestamp":1069384440000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["Cholinergic medication for neuroleptic-induced tardive dyskinesia"],"prefix":"10.1002","author":[{"given":"Irina","family":"Tammenmaa","sequence":"first","affiliation":[{"name":"University of Helsinki; Department of Psychiatry; Lapinlahti Hospital P.O.Box 320 FIN-00029 Helsinki University Central Hospital Finland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"McGrath","sequence":"additional","affiliation":[{"name":"Queensland Brain Institute, Queensland Centre for Mental Health Research; University of Queensland Brisbane Queensland Australia QLD 4072"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eila ES","family":"Sailas","sequence":"additional","affiliation":[{"name":"National reseearch and development centre for welfare and health; PO Box 220 Helsinki Finland 00531"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karla","family":"Soares-Weiser","sequence":"additional","affiliation":[{"name":"Enhance Reviews Ltd; Central Office, Cobweb Buildings The Lane, Lyford Wantage UK OX12 0EE"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2002,7,22]]},"reference":[{"key":"10.1002\/14651858.CD000207-BIB0001|cit1","volume-title":"Lecithin therapy for tardive dyskinesia [dissertation]","author":"Beckham","year":"1981"},{"key":"10.1002\/14651858.CD000207-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/BF00492207","article-title":"Ineffectiveness of deanol in tardive dyskinesia: a placebo controlled study","volume":"65","author":"Montigny","year":"1979","journal-title":"Psychopharmacology"},{"issue":"4","key":"10.1002\/14651858.CD000207-BIB0003|cit3","first-page":"149","article-title":"A crossover study of lecithin treatment of tardive dyskinesia","volume":"51","author":"Gelenberg","year":"1990","journal-title":"Journal of Clinical Psychiatry"},{"key":"10.1002\/14651858.CD000207-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"68","DOI":"10.3109\/00048678109159413","article-title":"Double blind controlled trial of deanol in tardive dyskinesia","volume":"15","author":"George","year":"1981","journal-title":"Australian and New Zealand Journal of Psychiatry"},{"issue":"6","key":"10.1002\/14651858.CD000207-BIB0005|cit5","first-page":"725","article-title":"Cholinergic enhancement in tardive dyskinesia","volume":"24","author":"Jackson","year":"1978","journal-title":"Current Therapeutic Research"},{"issue":"1","key":"10.1002\/14651858.CD000207-BIB0006|cit6","first-page":"85","article-title":"Lecithin administration in tardive dyskinesia: clinical and biomedical correlates","volume":"16","author":"Jackson","year":"1981","journal-title":"Biological Psychiatry"},{"issue":"11","key":"10.1002\/14651858.CD000207-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1176\/ajp.136.11.1458","article-title":"Treatment of tardive dyskinesia with lecithin","volume":"136","author":"Jackson","year":"1979","journal-title":"American Journal of Psychiatry"},{"issue":"1","key":"10.1002\/14651858.CD000207-BIB0008|cit8","first-page":"103","article-title":"Zur Therapie mit Dimethylamino\u00e4thanol (Deanol) bei neuroleptikainduzierten Sp\u00e4tdyskinesien","volume":"126","author":"Kocher","year":"1980","journal-title":"Schweizer Archiv fur Neurologie, Neurochirurgie und Psychiatrie"},{"key":"10.1002\/14651858.CD000207-BIB0009|cit9","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/BF00369796","article-title":"Not available","volume":"222","author":"Bockenheimer","year":"1976","journal-title":"Archiv fur Psychiatrie und Nervenkrankheiten"},{"key":"10.1002\/14651858.CD000207-BIB0010|cit10","volume-title":"Uber die therapeutische Wirksamkeit von Dimethylaminoaethanol bei neuroleptikainduzierten Sp\u00e4thyperkinesen [dissertation]","author":"Lucius","year":"1978"},{"key":"10.1002\/14651858.CD000207-BIB0011|cit11","volume-title":"Lecithin treatment for tardive dyskinesia: a clinical evaluation [dissertation]","author":"Price","year":"1982"},{"key":"10.1002\/14651858.CD000207-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1001\/archneur.1977.00500240044007","article-title":"Deanol acetamidobenzoate treatment in choreiform movement disorders","volume":"34","author":"Tarsy","year":"1977","journal-title":"Archives of Neurology"},{"issue":"2","key":"10.1002\/14651858.CD000207-BIB0013|cit13","first-page":"267","article-title":"Experimental design and analysis for determination of improvement rating by video imaging - A double-blind placebo-controlled study for Meclofenoxate hydrochloride (Lucidril) in tardive dyskinesia","volume":"19","author":"Ojima","year":"1991","journal-title":"Rinsho Hyoka (Clinical Evaluation)"},{"issue":"3","key":"10.1002\/14651858.CD000207-BIB0014|cit14","first-page":"455","article-title":"Meclofenoxate hydrochloride (Lucidril) in tardive dyskinesia - A double-blind placebo-controlled study","volume":"18","author":"Yagi","year":"1990","journal-title":"Rinsho Hyoka (Clinical Evaluation)"},{"issue":"1","key":"10.1002\/14651858.CD000207-BIB0015|cit15","first-page":"87","article-title":"Lecithin treatment of tardive dyskinesia - a progress report","volume":"18","author":"Anderson","year":"1982","journal-title":"Psychopharmacology Bulletin"},{"issue":"12","key":"10.1002\/14651858.CD000207-BIB0016|cit16","first-page":"1445","article-title":"The safety of lecithin diet supplementation in schizophrenic patients","volume":"17","author":"Yackulic","year":"1982","journal-title":"Biological Psychiatry"},{"key":"10.1002\/14651858.CD000207-BIB0017|cit17","first-page":"303","article-title":"Lecithin in the treatment of tardive dyskinesia","volume":"3","author":"Branchey","year":"1979","journal-title":"Communications in Psychopharmacology"},{"issue":"10","key":"10.1002\/14651858.CD000207-BIB0018|cit18","doi-asserted-by":"crossref","first-page":"772","DOI":"10.4088\/JCP.v62n1004","article-title":"Treatment of tardive dyskinesia with donepezil: A pilot study","volume":"62","author":"Caroff","year":"2001","journal-title":"Journal of Clinical Psychiatry"},{"issue":"2","key":"10.1002\/14651858.CD000207-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"128","DOI":"10.4088\/JCP.v62n0210e","article-title":"Treatment of tardive dyskinesia with donepezil [letter]","volume":"62","author":"Caroff","year":"2001","journal-title":"Journal of Clinical Psychiatry"},{"issue":"8","key":"10.1002\/14651858.CD000207-BIB0020|cit20","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1176\/ajp.132.8.864","article-title":"Deanol in the treatment of tardive dyskinesia","volume":"132","author":"Casey","year":"1975","journal-title":"American Journal of Psychiatry"},{"key":"10.1002\/14651858.CD000207-BIB0021|cit21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/BF00426532","article-title":"Pharmacological characterization of tardive dyskinesia","volume":"54","author":"Casey","year":"1977","journal-title":"Psychopharmacology"},{"key":"10.1002\/14651858.CD000207-BIB0022|cit22","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/BF00427135","article-title":"Mood alterations during deanol therapy","volume":"62","author":"Casey","year":"1979","journal-title":"Psychopharmacology"},{"issue":"2","key":"10.1002\/14651858.CD000207-BIB0023|cit23","first-page":"20","article-title":"Efficacies of agents related to GABA, dopamine and acetylcholine in the treatment of tardive dyskinesia","volume":"14","author":"Chien","year":"1978","journal-title":"Psychopharmacology Bulletin"},{"key":"10.1002\/14651858.CD000207-BIB0024|cit24","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1056\/NEJM197504242921720","article-title":"Deanol for tardive dyskinesia","volume":"292","author":"Crane","year":"1975","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD000207-BIB0025|cit25","first-page":"71","article-title":"Treatment of phenothiazine induced bulbar persistent dyskinesia with deanol acetamidobenzoate","volume":"36","author":"Curran","year":"1975","journal-title":"Diseases of the Nervous System"},{"key":"10.1002\/14651858.CD000207-BIB0026|cit26","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1056\/NEJM197507172930317","article-title":"Choline for tardive dyskinesia","volume":"293","author":"Davis","year":"1975","journal-title":"New England Journal of Medicine"},{"issue":"10","key":"10.1002\/14651858.CD000207-BIB0027|cit27","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1016\/0024-3205(76)90095-3","article-title":"Choline in tardive dyskinesia and Huntington's disease","volume":"19","author":"Davis","year":"1976","journal-title":"Life Sciences"},{"issue":"7","key":"10.1002\/14651858.CD000207-BIB0028|cit28","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1176\/ajp.134.7.807","article-title":"Deanol in tardive dyskinesia","volume":"134","author":"Davis","year":"1977","journal-title":"American Journal of Psychiatry"},{"issue":"1","key":"10.1002\/14651858.CD000207-BIB0029|cit29","first-page":"23","article-title":"Pharmacological investigations of the cholinergic imbalance hypotheses of movement disorders and psychosis","volume":"13","author":"Davis","year":"1978","journal-title":"Biological Psychiatry"},{"issue":"5981","key":"10.1002\/14651858.CD000207-BIB0030|cit30","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1136\/bmj.3.5981.466","article-title":"Deanol in tardive dyskinesia","volume":"3","author":"Silva","year":"1975","journal-title":"British Medical Journal"},{"key":"10.1002\/14651858.CD000207-BIB0031|cit31","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1016\/0006-3223(85)90177-5","article-title":"Lack of clinically significant improvement of patients with tardive dyskinesia following phosphatidylcholine therapy","volume":"20","author":"Domino","year":"1985","journal-title":"Biological Psychiatry"},{"key":"10.1002\/14651858.CD000207-BIB0032|cit32","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1056\/NEJM197502062920617","article-title":"Dimethylaminoethanol for tardive dyskinesia","volume":"292","author":"Escobar","year":"1975","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD000207-BIB0033|cit33","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/BF00437417","article-title":"Cholinergic suppression of tardive dyskinesia","volume":"37","author":"Fann","year":"1974","journal-title":"Psychopharmacologia (Berlin)"},{"key":"10.1002\/14651858.CD000207-BIB0034|cit34","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/BF00429543","article-title":"Deanol in tardive dyskinesia: a preliminary report","volume":"42","author":"Fann","year":"1975","journal-title":"Psychopharmacologia (Berlin)"},{"key":"10.1002\/14651858.CD000207-BIB0035|cit35","first-page":"106","article-title":"Chronic deanol administration in tardive dyskinesia","volume":"19","author":"Fann","year":"1976","journal-title":"Clinical Pharmacology and Therapeutics"},{"issue":"6","key":"10.1002\/14651858.CD000207-BIB0036|cit36","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1176\/ajp.136.6.772","article-title":"Choline and lecithin in the treatment of tardive dyskinesia: preliminary results from a pilot study","volume":"136","author":"Gelenberg","year":"1979","journal-title":"American Journal of Psychiatry"},{"key":"10.1002\/14651858.CD000207-BIB0037|cit37","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1056\/NEJM197504242921720","article-title":"Deanol for tardive dyskinesia","volume":"292","author":"Granacher","year":"1975","journal-title":"New England Journal of Medicine"},{"issue":"4","key":"10.1002\/14651858.CD000207-BIB0039|cit38","first-page":"55","article-title":"Effects of choline on tardive dyskinesia and other movement disorders","volume":"14","author":"Growdon","year":"1978","journal-title":"Psychopharmacology Bulletin"},{"issue":"10","key":"10.1002\/14651858.CD000207-BIB0038|cit39","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1056\/NEJM197709082971002","article-title":"Oral choline administration to patients with tardive dyskinesia","volume":"297","author":"Growdon","year":"1977","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD000207-BIB0040|cit40","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1080\/21548331.1978.11707296","article-title":"Dietary enhancement of CNS neurotransmitters","volume":"13","author":"Wurtman","year":"1978","journal-title":"Hospital Practice"},{"issue":"1-2","key":"10.1002\/14651858.CD000207-BIB0041|cit41","first-page":"47","article-title":"Treatment of tardive dyskinesias with 7-metoxytacrine - II","volume":"36","author":"Hanus","year":"1993","journal-title":"Sbornik vedeckych praci Lekarske fakulty Karlovy univerzity v Hradci Kralove. Supplementum."},{"issue":"12","key":"10.1002\/14651858.CD000207-BIB0042|cit42","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1176\/ajp.140.12.1629","article-title":"The use of tacrine for tardive dyskinesia","volume":"140","author":"Ingram","year":"1983","journal-title":"American Journal of Psychiatry"},{"key":"10.1002\/14651858.CD000207-BIB0043|cit43","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/0006-3223(86)90142-3","article-title":"Meclofenoxate therapy in tardive dyskinesia: A preliminary report","volume":"21","author":"Izumi","year":"1986","journal-title":"Biological Psychiatry"},{"key":"10.1002\/14651858.CD000207-BIB0044|cit44","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1159\/000117629","article-title":"Deanol, lithium and placebo in the treatment of tardive dyskinesia: A double-blind crossover study","volume":"4","author":"Jus","year":"1978","journal-title":"Neuropsychobiology"},{"key":"10.1002\/14651858.CD000207-BIB0045|cit45","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1136\/jnnp.37.8.941","article-title":"Effect of cholinergic and anticholinergic agents on tardive dyskinesia","volume":"27","author":"Klawans","year":"1974","journal-title":"Journal of Neurology, Neurosurgery, and Psychiatry"},{"issue":"8","key":"10.1002\/14651858.CD000207-BIB0046|cit46","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1176\/ajp.133.8.978","article-title":"Treatment of tardive dyskinesia with deanol","volume":"133","author":"Kumar","year":"1976","journal-title":"American Journal of Psychiatry"},{"issue":"7919","key":"10.1002\/14651858.CD000207-BIB0047|cit47","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1016\/S0140-6736(75)92592-1","article-title":"Deanol in spontaneous and induced dyskinesias","volume":"1","author":"Laterre","year":"1975","journal-title":"Lancet"},{"issue":"4","key":"10.1002\/14651858.CD000207-BIB0048|cit48","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1097\/00004714-198808000-00004","article-title":"Pharmacologic characterization of tardive dyskinesia","volume":"8","author":"Lieberman","year":"1988","journal-title":"Journal of Clinical Psychopharmacology"},{"key":"10.1002\/14651858.CD000207-BIB0049|cit49","doi-asserted-by":"crossref","first-page":"415","DOI":"10.2466\/pr0.1979.45.2.415","article-title":"Electromyographic assessment of dimethylaminoethanol (deanol) in treatment of tardive dyskinesia","volume":"45","author":"Lonowski","year":"1979","journal-title":"Psychological Reports"},{"issue":"Number 3, Speci","key":"10.1002\/14651858.CD000207-BIB0050|cit50","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/0924-977X(94)90192-9","article-title":"An open trial with 7-methoxytacrine in tardive dyskinesia","volume":"4","author":"Marsalek","year":"1994","journal-title":"European Neuropsychopharmacology"},{"issue":"12","key":"10.1002\/14651858.CD000207-BIB0051|cit51","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1176\/ajp.133.12.1467a","article-title":"Failure of deanol in treating tardive dyskinesia","volume":"133","author":"Mehta","year":"1976","journal-title":"American Journal of Psychiatry"},{"issue":"10","key":"10.1002\/14651858.CD000207-BIB0052|cit52","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1176\/ajp.137.10.1202","article-title":"Identification of a subgroup of tardive dyskinesia patients by pharmacologic probes","volume":"137","author":"Moore","year":"1980","journal-title":"American Journal of Psychiatry"},{"key":"10.1002\/14651858.CD000207-BIB0053|cit53","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1017\/S0033291700015312","article-title":"Variable clinical response to choline in tardive dyskinesia","volume":"14","author":"Nasrallah","year":"1984","journal-title":"Psychological Medicine"},{"issue":"2","key":"10.1002\/14651858.CD000207-BIB0054|cit54","first-page":"56","article-title":"Pharmacologic probes of neurotransmitter systems in tardive dyskinesia: Implications for clinical management","volume":"47","author":"Nasrallah","year":"1986","journal-title":"Journal of Clinical Psychiatry"},{"key":"10.1002\/14651858.CD000207-BIB0055|cit55","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1007\/BF00431469","article-title":"Effect of a cholinomimetic drug (RS 86) in tardive dyskinesia and drug-related parkinsonism","volume":"84","author":"Noring","year":"1984","journal-title":"Psychopharmacology"},{"issue":"19","key":"10.1002\/14651858.CD000207-BIB0056|cit56","doi-asserted-by":"crossref","first-page":"1997","DOI":"10.1001\/jama.1978.03280460065020","article-title":"Double-blind evaluation of deanol in tardive dyskinesia","volume":"239","author":"Penovich","year":"1978","journal-title":"Journal of the American Medical Association"},{"key":"10.1002\/14651858.CD000207-BIB0057|cit57","first-page":"628","article-title":"Oral choline in tardive dyskinesia","volume":"76","author":"Ray","year":"1982","journal-title":"Indian Journal of Medical Research"},{"issue":"5","key":"10.1002\/14651858.CD000207-BIB0058|cit58","first-page":"289","article-title":"Cholinergic system in the pathophysiology of tardive dyskinesias","volume":"84","author":"Rektor","year":"1988","journal-title":"Ceskoslovenska Psychiatrie"},{"key":"10.1002\/14651858.CD000207-BIB0059|cit59","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1007\/BF00426709","article-title":"Deanol in the treatment of tardive dyskinesia","volume":"52","author":"Simpson","year":"1977","journal-title":"Psychopharmacology"},{"issue":"7","key":"10.1002\/14651858.CD000207-BIB0060|cit60","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1176\/ajp.134.7.769","article-title":"Cholinergic influences in tardive dyskinesia","volume":"134","author":"Tamminga","year":"1977","journal-title":"American Journal of Psychiatry"},{"key":"10.1002\/14651858.CD000207-BIB0061|cit61","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/0165-1781(86)90002-8","article-title":"Lithium and lecithin in tardive dyskinesia: an update","volume":"19","author":"Volavka","year":"1986","journal-title":"Psychiatry Research"},{"issue":"4","key":"10.1002\/14651858.CD000207-BIB0062|cit62","first-page":"305","article-title":"First experience with the application of 7-methoxytacrine to psychiatric patients","volume":"31","author":"Zapletalek","year":"1989","journal-title":"Activitas Nervosa Superior"},{"issue":"1","key":"10.1002\/14651858.CD000207-BIB0063|cit63","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0010-440X(89)90111-9","article-title":"CDP-Choline for the treatment of tardive dyskinesia: A small negative series","volume":"30","author":"Gelenberg","year":"1989","journal-title":"Comprehensive Psychiatry"},{"issue":"3","key":"10.1002\/14651858.CD000207-BIB0064|cit64","first-page":"197","article-title":"Effect of lecithin on tardive dyskinesia","volume":"22","author":"Joe","year":"1985","journal-title":"Korea University Medical Journal"},{"issue":"1","key":"10.1002\/14651858.CD000207-BIB0065|cit65","first-page":"7","article-title":"7-MEOTA in the treatment of tardive dyskinesia. Double-blind placebo controlled study","volume":"38","author":"Marsalek","year":"1997","journal-title":"Homeostasis: integrative brain functions in health and disease"},{"issue":"11","key":"10.1002\/14651858.CD000207-BIB0066|cit66","first-page":"531","article-title":"Double-blind study of lecithin in the treatment of persistent tardive dyskinesia","volume":"73","author":"Perez-Cruet","year":"1981","journal-title":"Boletin Asociacion Medica Puerto Rico"},{"key":"10.1002\/14651858.CD000207-BIB0067|cit67","unstructured":"Caroff SN Personal communication 2002"},{"key":"10.1002\/14651858.CD000207-BIB0068|cit68","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1159\/000408492","article-title":"Cholinergic treatments for tardive dyskinesia","volume":"21","author":"Alphs","year":"1983","journal-title":"Modern Problems in Pharmacopsychiatry"},{"key":"10.1002\/14651858.CD000207-BIB0069|cit69","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1136\/bmj.313.7066.1200","article-title":"Detecting skewness from summary information","volume":"313","author":"Altman","year":"1996","journal-title":"BMJ"},{"issue":"5","key":"10.1002\/14651858.CD000207-BIB0070|cit70","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/S0301-0082(99)00064-7","article-title":"Neurotoxicity associated with neuroleptic-induced oral dyskinesias in rats. Implications for tardive dyskinesia?","volume":"61","author":"Andreassen","year":"2000","journal-title":"Progress in Neurobiology"},{"issue":"1","key":"10.1002\/14651858.CD000207-BIB0071|cit71","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s002130100767","article-title":"Oral dyskinesias and morphological changes in rat striatum during long-term haloperidol administration","volume":"157","author":"Andreassen","year":"2001","journal-title":"Psychopharmacology (Berlin)"},{"key":"10.1002\/14651858.CD000207-BIB0072|cit72","volume-title":"Tardive dyskinesia: a task force report of the American Psychiatric Association","author":"American Psychiatric Association","year":"1992"},{"key":"10.1002\/14651858.CD000207-BIB0073|cit73","doi-asserted-by":"crossref","DOI":"10.1016\/B978-0-12-079035-7.50021-X","article-title":"The side-effects of antipsychotic drugs. I. CNS and neuromuscular effects","volume-title":"Antipsychotic drugs and their side-effects","author":"Barnes","year":"1993"},{"key":"10.1002\/14651858.CD000207-BIB0074|cit74","article-title":"Tardive dyskinesia: pathophysiology","volume-title":"Psychopharmacology. The Fourth Generation of Progress","author":"Casey","year":"1995"},{"issue":"suppl 4","key":"10.1002\/14651858.CD000207-BIB0075|cit75","first-page":"5","article-title":"Tardive dyskinesia: pathophysiology and animal models","volume":"61","author":"Casey","year":"2000","journal-title":"Journal of Clinical Psychiatry"},{"issue":"4","key":"10.1002\/14651858.CD000207-BIB0076|cit76","article-title":"Cochrane Reviewers\u00b4 Handbook 4.1.4 [updated October 2001]","author":"Clarke","year":"2001","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"suppl 4","key":"10.1002\/14651858.CD000207-BIB0077|cit77","first-page":"10","article-title":"Prevalence of spontaneous dyskinesia in schizophrenia","volume":"61","author":"Fenton","year":"2000","journal-title":"Journal of Clinical Psychiatry"},{"issue":"suppl 4","key":"10.1002\/14651858.CD000207-BIB0078|cit78","first-page":"15","article-title":"Review of incidence studies of tardive dyskinesia associated with typical antipsychotics","volume":"61","author":"Glazer","year":"2000","journal-title":"Journal of Clinical Psychiatry"},{"issue":"1","key":"10.1002\/14651858.CD000207-BIB0079|cit79","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1002\/1098-2396(20010101)39:1<51::AID-SYN7>3.0.CO;2-Z","article-title":"Decreased choline acetyltransferase immunoreactivity in discrete striatal subregions following chronic haloperidol in rats","volume":"39","author":"Grimm","year":"2001","journal-title":"Synapse"},{"key":"10.1002\/14651858.CD000207-BIB0080|cit80","first-page":"534","article-title":"Abnormal Involuntary Movement Scale (AIMS)","volume-title":"ECDEU Assessment Manual for Psychopharmacology. US Dept Health, Education and Welfare publication (ADM) 76-338","author":"Guy","year":"1976"},{"key":"10.1002\/14651858.CD000207-BIB0081|cit81","first-page":"217","article-title":"Clinical Global Impressions (CGI)","volume-title":"ECDEU Assessment Manual for Psychopharmacology. US Dept Health, Education and Welfare publication (ADM) 76-338","author":"Guy","year":"1976"},{"key":"10.1002\/14651858.CD000207-BIB0082|cit82","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0197-2456(95)00134-4","article-title":"Assessing the quality of reports of randomized clinical trials: Is blinding necessary?","volume":"17","author":"Jadad","year":"1996","journal-title":"Controlled Clinical Trials"},{"issue":"suppl 4","key":"10.1002\/14651858.CD000207-BIB0083|cit83","first-page":"27","article-title":"Tardive dyskinesia in older patients","volume":"61","author":"Jeste","year":"2000","journal-title":"Journal of Clinical Psychiatry"},{"issue":"4","key":"10.1002\/14651858.CD000207-BIB0084|cit84","article-title":"Non-neuroleptic catecholaminergic drugs for neuroleptic-induced tardive dyskinesia (Protocol for a Cochrane Review)","author":"Lyra da Silva","year":"2001","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD000207-BIB0085|cit85","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1192\/bjp.176.3.249","article-title":"Unpublished rating scales: a major source of bias in randomized controlled trials of treatments for schizophrenia","volume":"176","author":"Marshall","year":"2000","journal-title":"British Journal of Psychiatry"},{"issue":"4","key":"10.1002\/14651858.CD000207-BIB0086|cit86","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD000209","article-title":"Benzodiazepines for neuroleptic-induced tardive dyskinesia (Cochrane Review)","author":"McGrath","year":"2001","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"4","key":"10.1002\/14651858.CD000207-BIB0087|cit87","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD000209","article-title":"Miscellaneous treatments for neuroleptic-induced tardive dyskinesia (Cochrane Review)","author":"McGrath","year":"2001","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"4","key":"10.1002\/14651858.CD000207-BIB0088|cit88","article-title":"Neuroleptic reduction and\/or cessation and neuroleptics as specific treatments for tardive dyskinesia (Cochrane Review)","author":"McGrath","year":"2001","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD000207-BIB0089|cit89","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/0006-3223(93)90044-E","article-title":"Loss of striatal cholinergic neurons as a basis for tardive dyskinesia and L-dopa-induced dyskinesia, neuroleptic-induced supersensitivity psychosis and refractory schizophrenia","volume":"34","author":"Miller","year":"1993","journal-title":"Biological Psychiatry"},{"key":"10.1002\/14651858.CD000207-BIB0090|cit90","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1001\/jama.285.15.1987","article-title":"The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomized trials","volume":"285","author":"Moher","year":"2001","journal-title":"JAMA"},{"key":"10.1002\/14651858.CD000207-BIB0091|cit91","first-page":"431","article-title":"Clinical research for the treatment of schizophrenia","volume":"29","author":"Schooler","year":"1993","journal-title":"Psychopharmacology Bulletin"},{"key":"10.1002\/14651858.CD000207-BIB0092|cit92","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1001\/jama.1995.03520290060030","article-title":"Empirical evidence of bias: dimensions of methodological quality associated with estimates of treatment effects in controlled trials","volume":"273","author":"Schulz","year":"1995","journal-title":"JAMA"},{"key":"10.1002\/14651858.CD000207-BIB0093|cit93","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/BF00496058","article-title":"A rating scale for tardive dyskinesia","volume":"64","author":"Simpson","year":"1979","journal-title":"Psychopharmacology"},{"issue":"4","key":"10.1002\/14651858.CD000207-BIB0094|cit94","article-title":"Anticholinergic medication for neuroleptic-induced tardive dyskinesia (Cochrane Review)","author":"Soares","year":"2001","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"4","key":"10.1002\/14651858.CD000207-BIB0095|cit95","article-title":"Calcium channel blockers for neuroleptic-induced tardive dyskinesia (Cochrane Review)","author":"Soares","year":"2001","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"4","key":"10.1002\/14651858.CD000207-BIB0096|cit96","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD000203","article-title":"Gamma-aminobutyric acid agonists for neuroleptic-induced tardive dyskinesia (Cochrane Review)","author":"Soares","year":"2001","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"4","key":"10.1002\/14651858.CD000207-BIB0097|cit97","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD000203","article-title":"Vitamin E for neuroleptic-induced tardive dyskinesia (Cochrane Review)","author":"Soares","year":"2001","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"2","key":"10.1002\/14651858.CD000207-BIB0098|cit98","article-title":"Cholinergic medication for neuroleptic-induced tardive dyskinesia","author":"McGrath","year":"1997","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"1","key":"10.1002\/14651858.CD000207-BIB0099|cit99","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0920-9964(99)00021-3","article-title":"The treatment of tardive dyskinesia - a systematic review and meta-analysis","volume":"39","author":"Soares","year":"1999","journal-title":"Schizophrenia Research"}],"updated-by":[{"DOI":"10.1002\/14651858.cd000207.pub2","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2018,3,19]],"date-time":"2018-03-19T00:00:00Z","timestamp":1521417600000}}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1002\/14651858.CD000207\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,9]],"date-time":"2021-08-09T20:55:23Z","timestamp":1628542523000},"score":1,"resource":{"primary":{"URL":"https:\/\/doi.wiley.com\/10.1002\/14651858.CD000207"}},"subtitle":[],"editor":[{"name":"Cochrane Schizophrenia Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2002,7,22]]},"references-count":99,"URL":"https:\/\/doi.org\/10.1002\/14651858.cd000207","relation":{"new_version":[{"id-type":"doi","id":"10.1002\/14651858.CD000207.pub2","asserted-by":"object"}]},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2002,7,22]]}}}